Healthcare Press Releases

The Church of Scientology held a rally to raise awareness of the continued use of Electro Convulsive Therapy and demand its ban as a mental health tool.

SACRAMENTO, CALIFORNIA, UNITED STATES, May 18, 2019 /EINPresswire.com/ — Marking the International Day Against Electro Convulsive Therapy, the Church of Scientology of Sacramento played host to Reverend Frederick Shaw, Jr. who came with an impassioned message to rally support for a protest march happening Saturday May 18th in San Francisco against the American Psychiatric Association where they are hosting their annual convention. The purpose of the march is to not only raise awareness that indeed ECT is still in use today but to demand an end to its use and urge a ban of ECT as a mental health treatment.

Reverend Shaw is a past-President of the Compton Branch of the NAACP, and the first President from Compton to be appointed to a California State Chair overseeing “The Children’s Task Force.” As the President of the NAACP, he lobbied the US Congress alongside the Citizens Commission on Human Rights to get passed into law the Child Medication Safety Act, which gives parents the right to refuse psychiatric drugs for their children as a provision for attending school.

He is now taking on ECT and calling out psychiatrists to end this abusive therapy. He also voiced concerns about psychiatrists being granted too much authority in law to hold, seize and treat people against their will and urged all present to attend the protest and let their voices be heard on this matter and other issues of importance.

The Church of Scientology has a long standing history of standing up for human rights in the field of Mental Health and, along with Professor of Psychiatry Dr. Thomas Szaz, co-founded the Citizens Commission on Human Rights in 1969 to help expose and abolish human rights abuses and the physically damaging practices in the field of Mental Health.

The Public Affairs Director for the local Church in Sacramento told attendees, “It is very much a part of the Church’s Founder L. Ron Hubbard’s vision that Scientologists work to restore the field of mental health to a more humanitarian approach and stand up for those abused and damaged by psychiatric treatment.”

For more information about the Church and the Citizens Commission on Human Rights visit them on their websites at: https://www.scientology-sacramento.org/ and https://www.cchr.org/

Mike Klagenberg
Church of Scientology of Sacramento
+1 (916) 801-0671
email us here

Source: EIN Presswire

Free eBooks are available to women suffering from serious health problems associated with the use of synthetic mesh slings.

SANTA BARBARA, CA, UNITED STATES, May 17, 2019 /EINPresswire.com/ — Women suffering from serious health problems associated with the use of synthetic mesh slings need expert medical evaluation and treatment. In a recently published video series, Michael Hibner, M.D., Ph.D., who is Board Certified in Urogynecology and a Chronic Pelvic Pain Specialist, discusses neuromuscular complications of polypropylene transobturator and retropubic slings used for the surgical management of stress urinary incontinence (SUI). This programming is available on the Pudendal Educational Portal.

Dr. Hibner provides crucial insights into the comprehensive treatment plan provided at a specialized women’s pelvic pain clinic. Dr. Hibner outlines a proper case evaluation, removal surgery, reconstructive surgery and ongoing therapies to improve the patient’s quality of life with better function and pain relief.

Dr. Greg Vigna, MD, JD, is Board Certified in Physical Medicine and Rehabilitation, a Certified Life Care Planner, and National Pharmaceutical Injury Attorney. He has produced free eBooks focused on Chronic Pelvic Pain with Dr. Hibner to educate women with mesh related complications as to what highly specialized diagnostic and treatment options have been providing the most favorable results. Dr. Vigna continues to contribute his expertise on neuromuscular complications of the TVM devices, bringing these critical issues to the forefront of women’s health.

Dr. Vigna and his team of seasoned trial lawyers pursue mesh cases involving women diagnosed with chronic nerve pain such as pudendal neuralgia, complex regional pain syndrome, or obturator neuralgia. These cases are inside and outside the TVM West Virginia Multidistrict Litigation (MDL). Dr. Vigna is the first attorney to have pudendal neuralgia clients filed in State Courts in Arizona and California after the MDL closed its doors to new cases.

Dr. Vigna states, “We are filing new injury cases involving transobturator and retropubic slings in State Court. We have cases with symptoms that develop immediately after implantation and cases that become symptomatic eight years after implantation. The diagnosis of pudendal neuralgia and obturator neuralgia is not a prerequisite to my representation. We are investigating cases with severe pain and disability and will look to file these cases in State Courts across the country.”

For videos, information, and resources, visit https://tvm.lifecare123.com/ or call 800-761-9206.

Greg Vigna
Greg Vigna, M.D., J.D.
1-800-761-9206
email us here

Source: EIN Presswire

Colorado Perinatal Care Quality Collaborative (CPCQC) is thrilled to announce CO has joined the national Alliance for Innovation on Maternal Health (AIM).

DENVER, CO, US, May 17, 2019 /EINPresswire.com/ — FOR IMMEDIATE RELEASE
May 17, 2019

CONTACT: Jaime Cabrera, Executive Director and Media Contact
jcabrera@cpcqc.org
303-630-9691

COLORADO JOINS THE ALLIANCE FOR INNOVATION ON MATERNAL HEALTH (AIM)

DENVER, CO – In Colorado, maternal death rates have been rising and 80% of those deaths have been determined preventable. In response to this crisis facing Colorado’s moms and babies, Colorado Perinatal Care Quality Collaborative (CPCQC) is thrilled to announce that our state has joined the national Alliance for Innovation on Maternal Health (AIM). CPCQC is the lead organization of this statewide effort.

With funding from the Health Resource Services Administration, AIM aligns national, state, and hospital level efforts to improve maternal health and safety. AIM’s specific strategies include broad partnerships, tools and technical assistance, implementation and training, real time data, building on existing initiatives, and specific bundle incremental adoption.

The AIM program will provide evidence based front line resources for birthing facilities and provider/public health teams to adapt and implement a series of action steps on high-risk maternal conditions to improve care processes and patient outcomes. Initially, participating Colorado hospitals will implement the Safe Reduction of Primary Cesarean Birth Maternal Safety Bundle, one of several AIM Patient Safety Bundles. Additional patient safety bundles will be prioritized and implemented in the coming months.

An informational luncheon is set for June 24th from 12:00p.m. to 2:00p.m. at 101 Monroe St. Denver, CO 80206. This is an opportunity to hear from AIM and CPCQC leadership about the work ahead, resources available, and how hospitals can engage in the program. This luncheon is open to all and anyone interested can RSVP by clicking here or emailing info@cpcqc.org for more information. If your hospital is interested in participating and unable to attend the information session, please contact us to discuss a potential site visit.

About CPCQC: Colorado Perinatal Care Quality Collaborative (CPCQC) is a statewide nonprofit network of hospitals, healthcare facilities, clinicians and public health professionals that improves the health of women and infants through continuous quality improvement. For more information, visit www.cpcqc.org.

To learn more about AIM, visit https://safehealthcareforeverywoman.org/aim-program/.

# # #

Jaime Cabrera
Colorado Perinatal Care Quality Collaborative
+1 303-630-9691
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Source: EIN Presswire

Emergency room staff nurse Victoria LoConte offers a closer look at the charitable fund established to honor her late uncle, Ronald LoConte.

LYNN, MASSACHUSETTS, USA, May 17, 2019 /EINPresswire.com/ — Described as gentle, kind, and a peacekeeper, Ronald LoConte relocated from his hometown of Everett, Massachusetts, to Molokai in Hawaii as a young man in order to begin a more selfless, off-grid way of life. Later, he would join the Peace Corps, subsequently spending time in more impoverished nations such as Guatemala, before sadly losing his life to cancer. Here, Victoria LoConte offers a closer look at the charitable fund established in his name and reveals more about her much-loved late uncle.

"After my uncle, Ronald LoConte, very sadly passed away, my family had a square in our hometown of Everett, Massachusetts, adjacent to the city hall, memorialized in his name," reveals Victoria. "We also started the Ronald LoConte Fund," she continues, "subsequently supporting terminally ill children, struggling families, and others in need with all manner of help, gifts, and further assistance."

Described by the family as a gentle and kind peacekeeper, in life, they say, Ronald LoConte selflessly cared for those in need, whether they be friends, family members, or complete strangers.

"After graduating from Brown University, he moved to the island of Molokai in Hawaii to live off-grid, before deciding to join the Peace Corps," reveals Victoria. Here, she says, Ronald became immaterialist and discovered a passion for serving more impoverished nations, later spending time in countries such as Guatemala.

Capable of promptly picking up new languages and regional dialects, locals quickly developed an affinity for her uncle Ronald, says Victoria. "My father, Vincent, often recalls how the children of Guatemala playfully nicknamed his brother 'Gigante Blanco,' or 'White Giant,'" she adds.

While serving in the Peace Corps, Ronald fell ill and was sent to the George Washington University Hospital. "It was at this time that doctors discovered and diagnosed my uncle with colon cancer that had metastasized to his liver," Victoria reveals.

Following surgery to remove a football-sized mass, Ronald was sent home to Everett to continue chemotherapy and radiation, ultimately saddened at seeing children also at the hospital receiving similar forms of cancer treatment to his own. "He said to his sisters, Anna and Maria, at the time, 'You know it's one thing for me as an adult to have cancer. I have lived a full life and have traveled, but these children; they haven't experienced their lives yet,'" explains Victoria.

Tragically, Ronald LoConte lost his fight against cancer on October 25, 1982. He was just 34 years old.

"Our family knew that they needed to keep Ronald's spirit of kindness, generosity, and passion for children alive," says Victoria, "and, in doing so, founded the Ronald LoConte Fund."

She continues, "Knowing the way he felt about children, his brother who was a nurse working at the Whidden Hospital at the time, spoke with the hospice unit's director and asked her to put him in contact with children who were living with terminal illnesses. From there, children were submitting their wishes, and my family was fulfilling them, providing bikes, video games, toys, boom boxes, and more."

A plaque remains with his name, Ronald LoConte, in a square memorialized in his honor at the corner of Broadway and Church Street in Everett, Massachusetts. With the recent passing of his sister, Maria LoConte, in 2018, the family wishes to reboot the fund's efforts by granting scholarships to high school students in the area hoping to major in medicine and other social services.

"It's because of my family residing in and serving the city of Everett, and thanks to the medical care provided from the Whidden Hospital, that I dreamed of becoming a nurse, and working there," reveals Victoria. "In 2017, I'm proud to say, I was able to fulfill this dream, and I continue to think fondly and often of my late uncle and all that he achieved," she adds, wrapping up.

Victoria LoConte is an emergency room staff nurse at CHA Everett Hospital in Everett, Massachusetts. She holds an associate's degree in nursing, obtained from the Lawrence Memorial School of Nursing with Regis College and a bachelor's degree in nursing from Southern New Hampshire University. Prior to her current position, LoConte has also worked as an urgent care facility nurse manager, a case manager, and as a skilled visiting nurse serving the Greater Boston area. Her experience includes adult, geriatric, and pediatric care.

Caroline Hunter
Web Presence, LLC
+1 786-551-9491
email us here

Source: EIN Presswire

LITTLETON, COLORADO, USA, May 17, 2019 /EINPresswire.com/ — Jay Brandenburg-Nau is a licensed counselor who helps clients from all over the world using an intensive therapeutic process to achieve peace, happiness, and a healthier outlook on life. He frequently employs the Enneagram model to teach his clients how understanding personality types and deep motivations can encourage personal growth.

Through counseling, Jay Brandenburg-Nau empowers clients in his local community and from around the world providing resources that help them achieve happiness and personal growth. After working as a youth pastor for a decade and earning a Master’s Degree in Clinical Mental Health Counseling from Denver Seminary, he has studied and employed a range of useful tactics to teach clients to understand their inner workings. One of the most helpful tools he uses in therapy is the Enneagram model for personality types.

“Through the Enneagram model, we can improve self-observation and gain a better understanding of what makes us tick and how we can be happiest,” says Jay Brandenburg-Nau. “What we can learn from the Enneagram helps us improve awareness and achieve a greater wholeness.”

When we think of personality models, the Myers Briggs test is likely to come to mind. The Myers Briggs helps many people bring awareness to their cognitive functions and teaches them things they may not have understood about themselves before. Similarly, the Enneagram model also offers a means to observe personality traits and mechanisms, which in turn allows clients of Jay Brandenburg-Nau to satisfy deeply-rooted needs and improve their overall well-being.

The Enneagram is based on nine different personality types or styles that represent a certain world outlook or archetype and influence the way people think, feel, and act. This can mean responses to things going on the world as well as responses to what’s happening inside their own hearts and minds. It delivers more practical information and core personality traits than the Myers Briggs and helps people uncover deep motivations, fears, and defense mechanisms that lie in their subconscious.

On one hand, the Enneagram seems like a model of nine specific traits that ask people to identify with a single one. Instead, it’s likely most or all people find something familiar in each of the personality types. The goal of the model is to discover the one type that dominates all the others, while using the neighboring two trait types to help determine the strongest influences. In this way, people learn that their behavior isn’t always a good representation of their personality. Through the Enneagram, they uncover deep motivations that steer their overall actions and behaviors.

“We’re all born with one of the nine dominating personality types from the Enneagram,” says Jay Brandenburg-Nau. “This type has a big influence on how we adapt to our early environments and ultimately how we respond to life factors later on.”

Through the Enneagram model, counselors like Jay Brandenburg-Nau help clients uncover the deep mechanisms that rule their behavior, perspectives, and motivations so they can learn to be their happiest and healthiest selves.

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here

Source: EIN Presswire

Doctor Formulated CBD Available from Curativa Bay Beginning May 20,2019

CLEARWATER, FLORIDA, USA, May 17, 2019 /EINPresswire.com/ — CLEARWATER, Fla., May 17, 2019 /PRNewswire/ — Curativa Bay Inc, known for their Breakthrough Organic Skincare Technology, Hypochlorous Acid (HOCL) and Natural Skin Care Formulations has just completed a Joint Venture to provide organically grown Hemp Derived Cannabidiol (CBD) products manufactured according to FDA guidelines in a Pharmaceutical setting. Curativa Bay’s organically grown, Full Spectrum CBD formulated into their extensive line by a board-certified Pharmacologist and Toxicologist insuring quality by testing in certified 3rd Party laboratories.

Their team of Medical Doctors, Pharmacologist and Toxicologist formulate these products in concert with third party testing laboratories to determine exact composition of Cannabinoids and Terpenes, as well as any potential toxicological contaminates. Once their testing is complete and cleared they add to a proprietary blend of Terpenes and organic plant extracts developed by their board certified Pharmacologist and Toxicologist. The blend is then tested a second time in a 3rd party laboratory to ensure the cannabinoid content is as advertised.

The cannabinoid, CDB, is non psychoactive, meaning users will feel neither High nor Stoned when applying or consuming their products. CDB is anti-anxiety, anti-inflammatory and an antioxidant making it a power combatant against anxiety, stress, pain and inflammation.

Curativa Bay (www.curativabay.com) is a boutique Veteran Owned skin care/ health and beauty manufacturer located in Clearwater Florida providing innovative natural health and beauty solutions with an emphasis on disruptive natural technologies.

Media Contact
William Maher
727-742-6636
4707 140th Avenue North Suite 210
Clearwater, Florida 33762

William Maher
curativa bay
+1 727-742-6636
email us here

What Customers Say of Curativa Bay

Source: EIN Presswire

Wiseguyrerports.Com Presents "Global Condensed Milk Market Size, Status And Free Sample Report Forecast 2019-2025" New Document To Its Studies Database.

PUNE, MAHARASHTRA, INDIA, May 17, 2019 /EINPresswire.com/ —

Condensed Milk Market – 2019

Wiseguyreports.Com Adds "Condensed Milk -Market Demand, Growth, Opportunities And Analysis Of Top Key Player Free Sample Report Forecast To 2025" To Its Research Database.

Description:

Condensed milk is cow's milk from which water has been removed.
Condensed milk is used in numerous dessert dishes in many countries.
The global Condensed Milk market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Condensed Milk market based on company, product type, end user and key regions.

This report studies the global market size of Condensed Milk in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Condensed Milk in these regions.
This research report categorizes the global Condensed Milk market by top players/brands, region, type and end user. This report also studies the global Condensed Milk market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Free Sample Report »

https://www.wiseguyreports.com/sample-request/3357137-global-condensed-milk-market-insights-forecast-to-2025

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alaska Milk
Amul
Arla Foods
Dairymen’s League
DaWan
Borden Food
Panda Dairy
Tatramilk

Market size by Product
Whole Condensed Milk with Sugar
Sweetened Condensed Milk
Boiled Condensed Milk
Unsweetened Concentrated Milk
Choice Condensed Milk
Condensed Milk with Coffee & Cocoa
Market size by End User
Caramel
Candies
Sweets
Cakes
Jams
Beverages

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Condensed Milk market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Condensed Milk market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Condensed Milk companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Condensed Milk submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Group Condensed Milk are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.

Click Here For Complete Report »

https://www.wiseguyreports.com/reports/3357137-global-condensed-milk-market-insights-forecast-to-2025

Major Key Points In Table Of Content:

1 Study Coverage
1.1 Condensed Milk Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Condensed Milk Market Size Growth Rate by Product
1.4.2 Whole Condensed Milk with Sugar
1.4.3 Sweetened Condensed Milk
1.4.4 Boiled Condensed Milk
1.4.5 Unsweetened Concentrated Milk
1.4.6 Choice Condensed Milk
1.4.7 Condensed Milk with Coffee & Cocoa
1.5 Market by End User
1.5.1 Global Condensed Milk Market Size Growth Rate by End User
1.5.2 Caramel
1.5.3 Candies
1.5.4 Sweets
1.5.5 Cakes
1.5.6 Jams
1.5.7 Beverages
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Condensed Milk Market Size
2.1.1 Global Condensed Milk Revenue 2014-2025
2.1.2 Global Condensed Milk Sales 2014-2025
2.2 Condensed Milk Growth Rate by Regions
2.2.1 Global Condensed Milk Sales by Regions
2.2.2 Global Condensed Milk Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Condensed Milk Sales by Manufacturers
3.1.1 Condensed Milk Sales by Manufacturers
3.1.2 Condensed Milk Sales Market Share by Manufacturers
3.1.3 Global Condensed Milk Market Concentration Ratio (CR5 and HHI)
3.2 Condensed Milk Revenue by Manufacturers
3.2.1 Condensed Milk Revenue by Manufacturers (2014-2019)
3.2.2 Condensed Milk Revenue Share by Manufacturers (2014-2019)
3.3 Condensed Milk Price by Manufacturers
3.4 Condensed Milk Manufacturing Base Distribution, Product Types

…

11 Company Profiles
11.1 Alaska Milk
11.1.1 Alaska Milk Company Details
11.1.2 Company Business Overview
11.1.3 Alaska Milk Condensed Milk Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Alaska Milk Condensed Milk Products Offered
11.1.5 Alaska Milk Recent Development
11.2 Amul
11.2.1 Amul Company Details
11.2.2 Company Business Overview
11.2.3 Amul Condensed Milk Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amul Condensed Milk Products Offered
11.2.5 Amul Recent Development
11.3 Arla Foods
11.3.1 Arla Foods Company Details
11.3.2 Company Business Overview
11.3.3 Arla Foods Condensed Milk Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Arla Foods Condensed Milk Products Offered
11.3.5 Arla Foods Recent Development
11.4 Dairymen’s League
11.4.1 Dairymen’s League Company Details
11.4.2 Company Business Overview
11.4.3 Dairymen’s League Condensed Milk Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Dairymen’s League Condensed Milk Products Offered
11.4.5 Dairymen’s League Recent Development
11.5 DaWan
11.5.1 DaWan Company Details

Continued …

About Us:

“Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Free Sample Report Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories”.

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

Sales@Wiseguyreports.Com

Http://Www.Wiseguyreports.Com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

NORAH TRENT
Wise Guy Reports
841 198 5042
email us here
["facebook", "twitter", "linkedin"]
{"facebook"=>"", "twitter"=>"", "linkedin"=>""}

Source: EIN Presswire

NAIROBI, KENYA, May 17, 2019 /EINPresswire.com/ — Merck Foundation, the philanthropic arm of Merck KGaA Germany underscored their commitment to build healthcare capacity in Kenya during a high level meeting held at the State House between The First Lady of Kenya, H.E. MADAM MARGARET KENYATTA and Dr. Rasha Kelej, CEO of Merck Foundation.

The First Lady of Kenya, H.E. MADAM MARGARET KENYATTA emphasized, “It was an honor and to meet and hold talks with the Chief Executive Officer of Merck Foundation, Dr. Rasha Kelej. I am looking forward to partnering in the training of more oncologists and experts in diabetes and infertility management, as well as in @BeyondZeroKenya.”

https://twitter.com/firstladykenya/status/1125806759933829121?s=21

Dr. Rasha Kelej, CEO of Merck Foundation and President, Merck More Than a Mother explained, “I am proud and elated to meet Her Excellency The First Lady of Kenya, MADAM MARGARET KENYATTA to discuss Merck Foundation’s commitment to improve the health and wellbeing of people of Kenya by improving access to quality and equitable healthcare in the country by training more doctors in the fields of Fertility, Cancer and Diabetes care through nationwide programs. Also, to work closely to break the stigma of infertility in Kenya and other African countries.”

About Merck Foundation in Kenya:

Merck Foundation launched ‘Empowering Berna’ project under the flagship global program ‘Merck More than a Mother’ in Africa to help childless and infertile women starting their own business and thus achieve financial independence and become stronger and happier. The project has benefited more than 100 women across Kenya.
Merck Foundation has provided embryology training on fertility specialty to Kenyan doctors in the past two years and will continue this program to improve access to quality and equitable fertility care in the country.

Merck Foundation has developed two-year oncology fellowship program in partnership with University of Nairobi, Kenya to improve cancer care in the country. Merck foundation has enrolled six doctors and will continue to enroll more in the next five years with the aim to build cancer care capacity nationwide.

Merck Foundation has also provided eight Kenyan doctors with one year diabetes and hypertension diploma and will continue to enroll more doctors from all counties in collaboration with local governments in the next five years through their nationwide Merck Foundation Diabetes blue points project in Kenya.
Moreover, Merck Foundation also provided first ever Health Media Training to more than 150 journalists from different part of Kenya to benefit in understanding the infertility issue in African communities and to learn the best media practices to cover such issues and raise awareness by following international standards of reporting and media ethics.
Merck Foundation also partnered with local singers to produce songs to address infertility stigma and empower infertile women in their communities. The songs were produced by Octopizzo and Suzan.

About ‘Merck More Than a Mother’ campaign;

“Merck More Than a Mother” initiative aims to empower infertile women through access to information, education and health and by changing mind-sets. This powerful initiative supports governments in defining policies to enhance access to regulated, safe and effective fertility care. It defines interventions to break the stigma around infertile women and raises awareness about infertility prevention and management. In partnership with academia, ministries of health and international fertility societies, the initiative also provides medical education and training for healthcare providers and embryologists to build and advance fertility care capacity in Africa and developing countries.

With “Merck More than a mother”, we have initiated a cultural shift to de-stigmatize infertility on all levels: By improving awareness, training the skills of local experts, building advocacy in cooperation with decision makers and by supporting childless women in starting their own small business. It’s all about giving every woman the respect and the help she deserves to live a fulfilling life, with or without a child.

The Ambassadors of “Merck More Than a Mother” are: H.E. NEO JANE MASISI, The First Lady of Botswana; H.E DENISE NKURUNZIZA, The First Lady of Burundi; H.E. BRIGITTE TOUADERA, The First Lady of Central African Republic; H.E. HINDA DEBY ITNO, The First Lady of Chad; H.E. ANTOINETTE SASSOU-NGUESSO, The First Lady of Congo; H.E. REBECCA AKUFO-ADDO, The First Lady of Ghana; H.E. FATOUMATTA BAH-BARROW, The First Lady of The Gambia; H.E. CONDÉ DJENE, The First Lady of Guinea Conakry; H.E. CLAR WEAH, The First Lady of Republic of Liberia; H.E. PROFESSOR GERTRUDE MUTHARIKA, The First Lady of Malawi; H.E. MARIAM MINT AHMAD TEKBER, The First lady of the Mauritania; H.E. DR. ISAURA FERRÃO NYUSI, The First Lady of Mozambique; H.E AÏSSATA ISSOUFOU MAHAMADO, The First Lady of Niger; H.E FATIMA MAADA, The First Lady of Sierra Leone; H.E. AUXILLIA MNANGAGW, The First Lady of Zimbabwe; H.E. ESTHER LUNGU, The First Lady of Zambia.

Also, part of the campaign is our Merck Embryology & Fertility Training Program, a three-month hands-on practical course in partnership with IRSI, Indonesia, IIRRH, India and Manipal Academy of Higher Education (Manipal University), India to establish the platform of fertility specialists across Africa and developing countries. Merck Foundation provided for more than 109 candidates, in clinical and practical training for fertility specialists and embryologists in more than 30 countries across Africa and Asia such as: Chad, Niger, Central African Republic, Cote D’Ivoire , Ghana, Ethiopia , Uganda, Kenya, Tanzania , Zambia , Nigeria, Benin, Mali, Burkina Fuso, Senegal, Guinea Conakry, Sierra Leone, Liberia, Cameron, Rwanda, Botswana, DR Congo , Congo Brazzaville, Gambia , Nepal, Sri Lanka, Bangladesh, Myanmar and Cambodia.

Merck Foundation is making history in many African countries where they never had fertility specialists or specialized fertility clinics before ‘Merck More Than a Mother’ intervention, to train the first fertility specialists such as; in Sierra Leone, Liberia, The Gambia, Niger, Chad, Guinea, Ethiopia and Uganda.

Diana Mbaluka
Digisphere Consulting
+254 736466513
email us here

Source: EIN Presswire

La Fondation Merck a rencontré la Première Dame du Kenya pour souligner son engagement à renforcer les capacités de soins de santé dans le pays

NAIROBI, KENYA, May 17, 2019 /EINPresswire.com/ — La Fondation Merck, la branche philanthropique de Merck KGaA Allemagne, a souligné son engagement à renforcer les capacités en matière de soins de santé au Kenya lors d'une réunion de haut niveau tenue à la Présidence entre La Première Dame du Kenya, S.E. MADAME MARGARET KENYATTA et Dr. Rasha Kelej, CEO Merck Foundation.

La Première Dame du Kenya, S.E. MADAME MARGARET KENYATTA a déclaré : « C’était un honneur de rencontrer et d’entretenir avec la Présidente Directrice Générale de la Fondation Merck, Dr. Rasha Kelej. Je suis impatient de collaborer à la formation d'un plus grand nombre d'oncologues et d'experts sur la prise en charge du diabète et de l'infertilité, ainsi que dans @BeyondZeroKenya. »

https://twitter.com/firstladykenya/status/1125806759933829121?s=21

Dr. Rasha Kelej, ‘CEO of Merck Foundation and President, Merck More Than a Mother’, a déclaré : « Je suis fière et ravie de rencontrer Son Excellence La Première Dame du Kenya, MADAME MARGARET KENYATTA, pour discuter de l’engagement de la Fondation Merck à améliorer la santé et le bien-être des habitants du Kenya en améliorant l'accès à des soins de qualité et équitables dans le pays en formant davantage de médecins dans les domaines de la Fertilité, du Cancer et du Diabète, par le biais de programmes nationaux. Aussi, travailler en étroite collaboration pour briser la stigmatisation liée à l'infertilité au Kenya et dans d'autres pays africains. »

À propos de la Fondation Merck au Kenya :

La Fondation Merck a lancé le projet « Empowering Berna » dans le cadre du programme mondial phare « Merck More than a Mother » en Afrique, pour aider les femmes infertiles et sans enfants à créer leur propre commerce et ainsi atteindre l’indépendance financière et devenir plus fortes et plus heureuses. Le projet a bénéficié à plus de 100 femmes à travers le Kenya.
La Fondation Merck a dispensé une formation en embryologie aux médecins Kényans sur la fertilité au cours des deux dernières années et poursuivra ce programme visant à améliorer l'accès à des soins de fertilité de qualité et équitables dans le pays.

La Fondation Merck a mis au point un programme de bourses de formation en oncologie d'une durée de deux ans en partenariat avec l'Université de Nairobi, au Kenya, afin d'améliorer les soins du cancer dans le pays. La Fondation Merck a inscrit six médecins et continuera à en inscrit davantage au cours des cinq prochaines années dans le but de renforcer les capacités de prise en charge du cancer dans tout le pays.
La Fondation Merck a également fourni à huit médecins Kényans une formation et un diplôme d'un an en Diabète et en Hypertension et continuera à inscrit davantage de médecins de tous les comtés en collaboration avec les gouvernements locaux au cours des cinq prochaines années, dans le cadre de leur projet national de points blues pour le diabète de la Fondation Merck au Kenya.

De plus, la Fondation Merck a également fourni la toute première formation en matière de santé à plus de 150 journalistes de différentes régions du Kenya, afin de mieux comprendre le problème de l'infertilité dans les communautés africaines et d'apprendre les meilleures pratiques médiatiques permettant de couvrir ces sujets et de les sensibiliser aux normes internationales en vigueur sur le reportage et l’éthique des médias.
La Fondation Merck s'est également associée à des chanteurs locaux pour produire des chansons visant à lutter contre la stigmatisation liée à l'infertilité et à autonomiser les femmes infertiles dans leurs communautés. Les chansons ont été produites par Octopizzo and Suzan.

À propos de la campagne « Merck More than a Mother » ;

L’initiative « Merck More Than a Mother » vise à autonomiser les femmes infertiles à travers l’accès à l’information, à l’éducation et à la santé et le changement de mentalités. Cette initiative puissante aide les gouvernements à définir des politiques visant à améliorer l'accès à des soins de fertilité réglementés, sûrs et efficaces. Elle définit les interventions visant à briser la stigmatisation autour des femmes infertiles et à sensibiliser la population sur la prévention et la prise en charge de l'infertilité. En partenariat avec les universités, les ministères de la santé et les sociétés de fertilité internationales, cette initiative propose également une formation médicale et des formations aux prestataires de soins de santé et aux embryologistes afin de développer et de renforcer les capacités en matière de soins de fertilité en Afrique et dans les pays en voie de développement.

Avec « Merck More Than a Mother », nous avons lancé un changement de culture visant à déstigmatiser l’infertilité à tous les niveaux : en sensibilisant davantage, en renforçant les compétences des experts locaux, en bâtissant un plaidoyer en coopération avec les décideurs et en aidant les femmes sans enfants à démarrer leur propre petits commerces. Il s’agit de donner à chaque femme le respect et l’aide qu’elle mérite pour mener une vie épanouissante, avec ou sans enfant.

Les ambassadrices de « Merck More Than a Mother » sont ; S.E. NEO JANE MASISI, La Première Dame du Botswana ; S.E. DENISE NKURUNZIZA, La Première Dame de la République du Burundi ; S.E. BRIGITTE TOUADERA, La Première Dame de la République Centrafricaine ; S.E. HINDA DEBY ITNO, La Première Dame du Tchad ; S.E. ANTOINETTE SASSOU-NGUESSO, La Première Dame du Congo ; S.E. REBECCA AKUFO-ADDO, La Première Dame du Ghana ; S.E. FATOUMATTA BAH-BARROW, La Première Dame de la Gambie ; S.E. DJÈNÈ CONDÈ, La Première Dame de Guinée-Conakry ; S.E. CLAR WEAH, La Première Dame de la République du Libéria ; S.E. PROFESSEUR GERTRUDE MUTHARIKA, La Première Dame du Malawi ; S.E. MARIAM MINT AHMAD TEKBER, La Première dame de la Mauritanie ; S.E. DR. ISAURA FERRÃO NYUSI, La Première Dame du Mozambique ; S.E. AISSATA ISSOUFOU MAHAMADOU, La Première Dame du Niger ; S.E. FATIMA MAADA BIO, La Première Dame de Sierra Leone S.E. AUXILLIA MNANGAGW, La Première Dame du Zimbabwe et S.E. ESTHER LUNGU, La Première Dame de Zambie.

Diana Mbaluka
Digisphere Consulting
+254 736 466513
email us here

Source: EIN Presswire

SMi Reports: Leading industry experts will be speaking and attending the inaugural Pharmaceutical Cleanroom Technology conference in London, UK.

LONDON, GREATER LONDON, UNITED KINGDOM, May 17, 2019 /EINPresswire.com/ — Pharmaceutical and biologics product development and manufacturing processes carry their progressive complexities, which consequently affect cleanliness requirements and outline of facilities. Compliance with the standards for product approval is very important and as a result manufacturing companies in various industries are dependent on cleanroom technology.

By 2025, the global cleanroom technology market is expected to reach nearly US$5 billion. With this in mind, SMi Group are pleased to announce the launch of the Pharmaceutical Cleanroom Technology Europe, taking place in London on the 9th and 10th October 2019.

For those interested in attending, the biggest early bird discount of £400 is ending on Friday 31st May 2019. Places can be reserved at http://www.cleanroomtechnology.co.uk/PR1

The 2-day conference will be chaired by James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society (PHSS).
James Drinkwater is Head of Aseptic processing technologies & GMP compliance for F Ziel Germany, supporting international projects from a base in the UK. As a subject matter expert in Barrier separation technology; Isolator / RABS and hydrogen peroxide vapour bio-decontamination, James is involved in applications of sterile pharmaceutical product Filling, Aseptic processing of APIs/ ATMPs and Sterility testing.
In addition to the role at F Ziel James has a voluntary role as Chairman of the not for profit society: PHSS – Pharmaceutical and Healthcare sciences society and leads the PHSS Aseptic processing & Bio-contamination special interest group.

James will also be opening the conference on day 2 presenting on Development of Aseptic-Containment strategies (ACS) for processing of new toxic, potent or bio-hazard sterile medicinal products and therapies.
The programme features over 16 expert industry leading caliber of speakers including:
Christopher Hansy, Senior QC Scientist, TAKEDA
Christoph has about 13 years of experience in the pharmaceutical industry. He is currently member of the Global Microbiology Team at Takeda and based in Vienna, Austria.
In his current role he provides subject matter expertise as well as technical leadership on microbiological matters, such as method related projects, microbial control strategies, and contamination/investigation support in a global role.
Christoph will be speaking on Implementation of a Global contamination control program – A field report on day one.

Pier Angelo Galligani, Past President, Member of the Board, ASCCA (Italian Cleanroom Society)
Pier, mechanical engineer, is Partner and Technical Director at Techniconsult, an engineering company based in Florence active in the life-science field. During the past 30 years Pier Angelo has got a deep experience in pharmaceutical processes and plants, clean systems engineering, HVAC applications, contamination control and validation.
Pier will be speaking on CFD as a Tool for Implementing Quality by Design in Pharmaceutical Cleanroom Projects on day one.

Birger Lerche-Jorgensen, HVAC responsible, SME, ALK-Abello A/S
Experience HVAC engineer in design, construction and validation of ventilation and clean room in pharmaceutical production sites in Denmark, China and Russia.
Birger has worked for 14 years in Novo Nordisk A/S and has carried out a variety of tasks: Responsible for HVAC at aseptic production sites. HVAC construction and validation aseptic filling site in China.
Birger will be speaking on HVAC on a green field filling plant project from CD to Validation on day two.
Steve Marnach, EMEA Training Manager & Critical Environments Sales and Marketing Specialist, Dupont De Nemours (Luxembourg) S A
Steve has a Masters’ degree in Business Administration and has joined DuPont in 1995. He is currently the EMEA Training Manager and critical environments marketing and specialist for DuPont Personal Protection, the chemical protective garments business that Steve has been working for since 2003. In his current role, Steve is providing training sessions on the selection and safe handling of chemical protective garments used in, amongst others, pharmaceutical production and GMP grade B, C and D cleanroom operations as well as giving technical support to health and safety specialists.
Steve will be speaking on Addressing new GMP Annex 1 requirements – selection of adequate cleanroom clothing that is part of efficient QRM system for aseptic manufacturing process on day one.

Christine Arbesser-Rastburg, Director, Head of Global Microbiology, TAKEDA
Christine has 35 years – 26 years in the pharmaceutical industry – of experience in the field of microbiology. She is currently leading the Global Microbiology Department at Takeda.
Christine has extensive expertise in microbiological test methods (including mycoplasma testing), contamination control and trouble-shooting, cleanroom management, critical systems, aseptic processes, training in microbiology, hygiene, and aseptic/cleanroom behaviour, auditing and inspection assistance. Together with her team she provides technical guidance, requirements, and support to the Takeda network.
Christine will be speaking on Microbial contamination investigation tool on day two.

There are also two half day pre-conference workshops on Tuesday 8th October on Environmental Classification, Qualification and Monitoring of GMP Controlled areas in the morning led by PHSS and the afternoon workshop will cover all aspects of Gowning Theory led by Irish Cleanroom Society & BioTekPro AB.

The newly released brochure with the full programme, workshop details, and speaker line-up is available to download online at http://www.cleanroomtechnology.co.uk/PR1

Proudly Sponsored By: CONTEC & DUPONT
If you are interested in sponsoring, exhibiting or speaking at this event, please contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pharmaceutical Cleanroom Technology Conference
Conference: 9th & 10th October 2019
Workshops: 8th October 2019
Copthorne Tara Hotel, London, UK
http://www.cleanroomtechnology.co.uk/PR1
#SMiCleanroom

—- END —-
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+44 7800890224
email us here

Source: EIN Presswire